Cirrhosis: waiting-list arithmetic and the “liver regeneration” pitch

The MELD score defines your calendar now. Transplant lists move slowly, sobriety or viral clearance is behind you, and the liver's famous ability to regenerate makes “regenerative infusions” sound almost logical. Clinics along the medical-tourism belt agree enthusiastically.

What the data says for this situation

Liver disease draws heavy research — 62 MSC studies (5 recruiting) in our snapshot, one of the highest counts we track. Trial results are more textured than most fields: several randomised studies (notably in decompensated cirrhosis and severe alcoholic hepatitis) reported short-term improvements in liver-function scores after MSC infusion; longer-term survival benefit remains unproven, replication outside a few centres is limited, and no regulator has approved any product. The gap between “MELD dipped for months in a trial” and “regenerate your liver” is where the sales pitch lives.

Questions worth asking any provider

1. Which randomised cirrhosis trial matches my aetiology and severity?
2. Does anything here interfere with my transplant listing or eligibility?
3. What liver scores will be tracked, at what intervals, by whom?
4. Hepatologist involvement: who owns my case medically?

Red flags specific to this situation

• “Avoid transplant” framing for decompensated disease
• Infusions sold without coordination with your transplant centre
• Alcohol-related cirrhosis treated without addressing ongoing intake

Cost context

Liver infusion packages abroad run €10,000–€25,000. Trial evidence covers score improvements over months, not transplant avoidance — price accordingly.

FAQ

Can stem cells regenerate a cirrhotic liver?

Trials show short-term function-score improvements in some settings; reversal of cirrhosis has not been demonstrated.

Could this hurt my transplant chances?

Uncoordinated treatment abroad can complicate listing — involve your transplant centre before anything.

→ Build questions for a specific provider · → Cost calculator

Interactive/editorial page by the StemCellAtlas research team. Where registry or literature counts appear, they use the dated 2026-08-29 snapshot. Browser-only tools do not send or store answers. Page generated 2026-08-29. See our editorial standards.